Fluconazole prophylaxis in preterm infants: a systematic review
Brazilian Journal of Infectious Diseases, 2017 Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.
Juliana Ferreira da Silva Rios +3 more
doaj +1 more source
Exploring hidden dimensions of soil fungal biodiversity: A simple technique to detect soil fungi resistant to antifungal compounds [PDF]
, 2010 Soils are known to be ultimate and complex reservoirs of microbial diversity. The complex dimensions of bacterial and fungal diversity in tropical soils and microbial community dynamics are underexplored.
Sonashia Velho-Pereira +1 more
core +1 more source
Advances in the Treatment of Mycoses in Pediatric Patients
Journal of Fungi, 2018 The main indications for antifungal drug administration in pediatrics are reviewed as well as an update of the data of antifungal agents and antifungal policies performed.
Elias Iosifidis +2 more
doaj +1 more source
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study [PDF]
, 2013 Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units in Spain and Germany ...
Wissing, Heimo +7 more
core +1 more source
Journal of Investigative Medicine High Impact Case Reports, 2017 Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications ...
Mayur D. Mody MD +3 more
doaj +1 more source
Antifungal prophylaxis in liver transplant recipients [PDF]
Liver Transplantation, 2009 Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection.
Eschenauer, Gregory A. +2 more
openaire +3 more sources
PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia [PDF]
, 2022 Mould-active antifungal prophylaxis is frequently used to prevent invasive fungal infection in patients with acute leukaemia being treated with intensive chemotherapy.
Allsup, David +5 more
core +1 more source
Turkish Journal of Hematology, 2018 Objective: Invasive fungal infections (IFIs) are a significant cause of morbidity and mortality among neutropenic patients undergoing chemotherapy for acute myeloid leukemia (AML) and stem cell transplantation.
Vildan Özkocaman +9 more
doaj +1 more source
A mixed community of actinomycetes produce multiple antibiotics for the fungus farming ant Acromyrmex octospinosus [PDF]
, 2010 BACKGROUND: Attine ants live in an intensely studied tripartite mutualism with the fungus Leucoagaricus gongylophorus, which provides food to the ants, and with antibiotic-producing actinomycete bacteria.
Bibb, Mervyn J. +29 more
core +1 more source
Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Fungi, 2021 Despite the recent introduction of mold-active antifungal prophylaxis (MAP), breakthrough invasive fungal infections (b-IFI) still represent a possible complication and a cause of morbidity and mortality in hematological patients and allogeneic ...
Carmine Liberatore +12 more
doaj +1 more source